Bloomios, Inc. (BLMS)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Dec 26, 2025
0.00%
Market Cap 6.79K
Revenue (ttm) 8.23M
Net Income (ttm) -39.61M
Shares Out 67.87M
EPS (ttm) -1.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500,000
Average Volume 1,037,714
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0001
Beta -0.53
RSI 37.88
Earnings Date Apr 17, 2026

About Bloomios

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company’s product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California. [Read more]

Sector Healthcare
Founded 2001
Country United States
Stock Exchange OTCMKTS
Ticker Symbol BLMS
Full Company Profile

Financial Performance

In 2022, Bloomios's revenue was $6.08 million, a decrease of -28.43% compared to the previous year's $8.49 million. Losses were -$13.77 million, 584.8% more than in 2021.

Financial Statements

News

There is no news available yet.